ACLS · Axcelis Technologies
Conviction · Medium · more likely to lead the S&P 500 over the next three months, by a modest margin
Wrong if: a daily close below $90.00
Note written ·
How this view changed
- · Rating raised from Low to Medium. Guidance, 5 November 2026: On 5 November 2026 Axcelis reported third-quarter revenue of $237.8 million against about $230 million guided and guided fourth-quarter revenue to about $275 million and non-GAAP earnings per share to about $1.50.
Price against the kill line
16.0% clear of its kill line on the 13 November 2026 close.
How to read this
The red mark is the price level of the published kill line: a close through it (a weekly close, on a weekly line) would prove the research note wrong on price. The dot is where the stock closed on 13 November 2026; a dot left of the mark has closed through its line.
The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.
The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides
Three months against the kill line
Daily closes, to . Red: the kill line, a daily close below $90.00, set on 12 November 2026. The shares are down 27.5% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.
Kill line
A daily close below $90.00, the 5 November 2026 report-day close, which would erase the whole rebound that followed the third-quarter report. Fourth-quarter 2026 revenue below the approximately $275 million guide would also show the case failing.
Research onlyNot in the portfolio.
Last catalyst
Key figures from the filings · Industrials
Quarter to 30 September 2026, filed 5 November 2026; valuation at the 13 November 2026 close
- Revenue, latest quarter ($M)
- 238
- Revenue, change on a year (%)
- +11.3
- Gross margin (%)
- 41.0
- Operating margin (%)
- 11.5
- Free cash flow, four quarters ($M)
- 59.9
- Price to earnings (×)
- 30.8
- Free-cash-flow yield (%)
- 1.9
All filed numbers
What Axcelis Technologies reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .
| Quarter to | Revenue ($M) | On a year (%) | Gross margin (%) | Operating margin (%) |
|---|---|---|---|---|
| first filed | 238 | +11.3 | 41.0 | 11.5 |
| first filed | 215 | +10.6 | 42.4 | 9.4 |
| first filed | 199 | +3.3 | 40.5 | 4.0 |
| first filed | 238 | −5.6 | 47.0 | 15.2 |
| first filed | 214 | −16.7 | 41.6 | 11.7 |
| first filed | 195 | −24.2 | 44.9 | 14.9 |
| Pre-tax income ($M) | 36.0 |
| Net income ($M) four quarters: 105 | 37.8 |
| Diluted shares, change on a year (%) against the quarter to 30 September 2025 | −1.1 |
| Operating cash flow ($M) | 70.2 |
| Capital spending ($M) | 10.2 |
| Free cash flow ($M) | 59.9 |
| Cash and short-term investments ($M) | 472 |
| Debt ($M) | Not available |
| Net cash, cash less debt ($M) | Not available |
| Deferred revenue ($M) +7.1% on a year | 138 |
| Backlog, orders not yet delivered ($M) | Not reported |
| Receivables ($M) | 155 |
| Inventory ($M) | 376 |
| Shareholders' equity ($M) | 1,113 |
| Market value ($M) | 3,225 |
| Enterprise value, market value plus net debt ($M) | Not available |
| Enterprise value to sales (×) | Not available |
| Enterprise value to operating income (×) | Not available |
| Price to earnings (×) | 30.8 |
| Price to book value (×) | 2.9 |
| Free-cash-flow yield (%) | 1.9 |
Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 4.7% of shares outstanding sold short, 4.7 days of average trading to cover, +0.7% since the previous report.
| Window | Bought | Sold |
|---|---|---|
| 90 daysfrom | $0 | $0 |
| 12 monthsfrom | $0 | $6.4M |
The thesis
Axcelis Technologies now has a company-specific case: it guided fourth-quarter 2026 revenue to about $275 million and non-GAAP earnings per share (EPS) to about $1.50 (Form 8-K, 5 November 2026). Those figures sit well above the $238.8 million revenue and $1.22 EPS estimates cited in company-news summaries of the report. The shares are rated modestly more likely than not to beat the S&P 500 over three months. Gross margin, and China's ruling on the Veeco merger, settle whether the case holds.
Third-quarter revenue was $237.8 million against the approximately $230 million guided on 6 August 2026. Non-GAAP EPS was $1.26 against about $1.11 guided. Non-GAAP gross margin was 41.2%, below the 42.7% of the second quarter, so the beat came on volume while profitability per dollar of sales slipped.
The merger timetable moved the other way. On 2 November 2026 Axcelis and Veeco Instruments said they now expect to close by the end of the first quarter of 2027, later than the second-half 2026 target. The companies also plan a new Hart-Scott-Rodino antitrust filing in the United States because the current clearance is about to expire.
Bullish and bearish views on Axcelis Technologies, Inc.
The bull case on Axcelis Technologies, Inc. (ACLS), in brief: fourth-quarter guide is far above estimates. The bear case: gross margin fell again.
Bull case
- Fourth-quarter guide is far above estimates. Axcelis guided revenue to about $275 million and non-GAAP EPS to about $1.50 (Form 8-K, 5 November 2026). Company-news summaries put the prior estimates at $238.8 million and $1.22.
- Third quarter beat its own guide. Revenue of $237.8 million compares with $213.6 million a year earlier and about $230 million guided. Non-GAAP EPS was $1.26 (Form 8-K, Exhibit 99.1, 5 November 2026).
- Orders are running ahead of shipments. An Earnings Whispers summary of the 5 November 2026 call reported backlog of $531 million, up from $452 million, and a systems book-to-bill ratio of 1.5. The company's release describes a strong increase in bookings without giving figures.
- The balance sheet carries cash. On 30 September 2026 cash and equivalents were $190.8 million, short-term investments $281.6 million and long-term investments $143.0 million (Form 8-K, 5 November 2026).
- An analyst kept a Buy. B. Riley Securities reiterated Buy on 6 November 2026 and set a $140 price target.
Bear case
- Gross margin fell again. Non-GAAP gross margin was 41.2% in the third quarter against 42.7% in the second (Form 8-K exhibits, 6 August 2026 and 5 November 2026). Management attributed the pressure to foreign exchange. The fourth-quarter guide gives no gross margin figure.
- The Veeco close slipped by at least a quarter. The companies said on 2 November 2026 that the all-stock merger should close by the end of the first quarter of 2027 and that there is no assurance of that timing. China's State Administration for Market Regulation (SAMR) approval is still pending.
- A new US filing adds a step. Closing is conditioned on the waiting period for the new Hart-Scott-Rodino submission expiring or ending early (company release, 2 November 2026).
- Growth may pause after the fourth quarter. The same Earnings Whispers summary reported management expects first-quarter 2027 revenue roughly flat with the fourth quarter.
- The analyst target was lowered. B. Riley cut its price target to $140 on 6 November 2026 while keeping its Buy rating. The shares closed at $111.17 on 11 November 2026.
Price setup
The shares closed at $111.17 on 11 November 2026, below the 50-day average of $115.31 and the 200-day average of $123.44. The three-month change is −22.3% against the $143.03 close of 13 August 2026. The 52-week high is $193.78 (intraday, 15 June 2026), and the last close is 42.6% below it. The 52-week closing low is $74.12 on 20 November 2025.
The reaction to the report came in two steps. The shares closed at $92.14 on 4 November 2026 and fell on the report day itself, then closed at $99.24 on 6 November 2026, $106.79 on 10 November 2026 and $111.17 on 11 November 2026. The market sold the shares into the report, then repriced after the guide.
The price still reflects heavy doubt: after the guide, the shares remain below both moving averages and 42.6% under the June high, with the merger delay and the margin slip as the live objections.
Catalysts ahead
- ~30 November 2026 (est.): Axcelis and Veeco make a new Hart-Scott-Rodino antitrust filing in the United States. Closing is conditioned on that waiting period expiring or ending early, so a clean filing keeps the first-quarter 2027 close target on track.
- ~10 February 2027 (est.): Fourth-quarter 2026 results, expected in early-to-mid February. It shows whether revenue reaches the approximately $275 million guide and whether gross margin recovers from 41.2%.
- ~31 March 2027 (est.): End of the first quarter of 2027, the companies' target for closing the Veeco merger. A SAMR clearance by then ends the regulatory uncertainty; a further slip or a remedy-conditioned ruling extends it for both companies' shares.
Elapsed catalysts
- 12 November 2026: Jeroen Delsman becomes chief financial officer, succeeding David Ryzhik. It completes the finance leadership change announced on 27 October 2026, ahead of the fourth-quarter guide of about $275 million being tested. (passed)
What would change the view
A daily close below $90.00, the 5 November 2026 report-day close, which would erase the whole rebound that followed the third-quarter report. Fourth-quarter 2026 revenue below the approximately $275 million guide would also show the case failing.
The risks this note tracks, each with what would confirm it:
- Gross margin keeps eroding even as revenue rises, so the revenue beat does not reach earnings. Confirmed by: fourth-quarter 2026 non-GAAP gross margin below the 41.2% of the third quarter when results are reported in February 2027.
- China's SAMR delays or conditions the Veeco merger, pushing the close beyond the first quarter of 2027. Confirmed by: a SAMR prohibition or remedy-conditioned clearance, a company filing disclosing termination, or a company statement moving the expected close past 31 March 2027.
- Order strength fades after the fourth quarter and revenue growth pauses. Confirmed by: first-quarter 2027 revenue guidance at or below the fourth-quarter level, or backlog falling below the $531 million reported on 5 November 2026.
- A semiconductor equipment sector decline continues to drive the shares regardless of company results. Confirmed by: peer equipment makers extending losses while Axcelis shares stay below the 200-day average of $123.44.
What it trades with
Axcelis trades with semiconductor equipment peers, and the autumn decline ran without a company filing. The merger is all-stock at 0.3575 Axcelis shares per Veeco share, so Veeco shares move with Axcelis shares and both reprice on a SAMR clearance or termination. China is both the merger's regulatory gatekeeper and a large end market for the company's equipment.
The evidence, claim by claim (7)
- Third-quarter 2026 revenue was $237.8 million versus $213.6 million a year earlier; non-GAAP EPS was $1.26; non-GAAP gross margin was 41.2%. Axcelis Form 8-K, Exhibit 99.1 · as of
- Fourth-quarter 2026 guidance: revenue of about $275 million, GAAP EPS of about $1.15 and non-GAAP EPS of about $1.50. Axcelis Form 8-K, Exhibit 99.1 · as of
- Cash and equivalents were $190.8 million, short-term investments $281.6 million and long-term investments $143.0 million at 30 September 2026. Axcelis Form 8-K, Exhibit 99.1 · as of
- Axcelis and Veeco now expect the merger to close by the end of the first quarter of 2027, with a new Hart-Scott-Rodino filing and SAMR approval pending. Axcelis/Veeco joint release and Form 8-K · as of
- Backlog was $531 million versus $452 million and systems book-to-bill was 1.5, per a summary of the third-quarter call. Earnings Whispers via Finviz · as of
- B. Riley Securities reiterated Buy and lowered its price target to $140. B. Riley Securities, company news · as of
- Second-quarter 2026 non-GAAP gross margin was 42.7% and revenue was $215.2 million. Axcelis Form 8-K, Exhibit 99.1 · as of
Sources
Related · shared themes
VECO
Veeco Instruments
Veeco Instruments' pending Axcelis merger now closes by end of Q1 2027, not 2026, and Q3 earnings missed estimates; China's SAMR ruling and…
TSM
Taiwan Semiconductor Manufacturing
Taiwan Semiconductor Manufacturing's record October sales of NT$586.89 billion put fourth-quarter revenue on pace for the top of guidance…
AMAT
Applied Materials
Applied Materials looks more likely to lag the S&P 500 over the next three months: a 12 November 2026 outlook for more than 30%…
ASML
ASML Holding
ASML Holding's shares look more likely to lag the S&P 500 than lead it while chip stocks reprice 2027 US data-centre spending risk, despite…